Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 6
2013 12
2014 11
2015 15
2016 9
2017 4
2018 3
2019 2
2020 4
2021 4
2022 9
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Campochiaro PA, Maass KF, Singh N, Barteselli G. Campochiaro PA, et al. Among authors: barteselli g. Ophthalmology. 2019 Nov;126(11):e88-e89. doi: 10.1016/j.ophtha.2019.06.020. Ophthalmology. 2019. PMID: 31635711 No abstract available.
Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration.
Holekamp NM, Campochiaro PA, Chang MA, Miller D, Pieramici D, Adamis AP, Brittain C, Evans E, Kaufman D, Maass KF, Patel S, Ranade S, Singh N, Barteselli G, Regillo C; all Archway Investigators. Holekamp NM, et al. Among authors: barteselli g. Ophthalmology. 2022 Mar;129(3):295-307. doi: 10.1016/j.ophtha.2021.09.016. Epub 2021 Sep 29. Ophthalmology. 2022. PMID: 34597713 Free article. Clinical Trial.
Clinical applications of choroidal imaging technologies.
Chhablani J, Barteselli G. Chhablani J, et al. Among authors: barteselli g. Indian J Ophthalmol. 2015 May;63(5):384-90. doi: 10.4103/0301-4738.159861. Indian J Ophthalmol. 2015. PMID: 26139797 Free PMC article. Review.
Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results.
Regillo C, Berger B, Brooks L, Clark WL, Mittra R, Wykoff CC, Callaway NF, DeGraaf S, Ding HT, Fung AE, Gune S, Le Pogam S, Smith R, Willis JR, Barteselli G. Regillo C, et al. Among authors: barteselli g. Ophthalmology. 2023 Jul;130(7):735-747. doi: 10.1016/j.ophtha.2023.02.024. Epub 2023 Mar 2. Ophthalmology. 2023. PMID: 36870451 Free article. Clinical Trial.
Multimodal Imaging of Vitreoretinal Lymphoma.
Mapelli C, Invernizzi A, Barteselli G, Pellegrini M, Tabacchi E, Staurenghi G, Viola F. Mapelli C, et al. Among authors: barteselli g. Ophthalmologica. 2016;236(3):166-174. doi: 10.1159/000447412. Epub 2016 Sep 15. Ophthalmologica. 2016. PMID: 27627063
Multimodal imaging in deferoxamine retinopathy.
Viola F, Barteselli G, DellʼArti L, Vezzola D, Mapelli C, Villani E, Ratiglia R. Viola F, et al. Among authors: barteselli g. Retina. 2014 Jul;34(7):1428-38. doi: 10.1097/IAE.0000000000000073. Retina. 2014. PMID: 24378427
Outer retinal tubulations response to anti-VEGF treatment.
Espina M, Arcinue CA, Ma F, Camacho N, Barteselli G, Mendoza N, Ferrara N, Freeman WR. Espina M, et al. Among authors: barteselli g. Br J Ophthalmol. 2016 Jun;100(6):819-23. doi: 10.1136/bjophthalmol-2015-307141. Epub 2015 Sep 30. Br J Ophthalmol. 2016. PMID: 26423451
67 results